Beruflich Dokumente
Kultur Dokumente
PLEASE TYPE and complete all of the applicable sections. Furnish information for each animal
species to be utilized. Submit the original and six copies of this form to the Chair of the IACUC.
You may also submit one copy of the grant or experimental proposal.
Following are points of information to assist you.
I.
LD50 STUDIES: If LD50 studies are performed, please provide justification when more
than five male and five female animals per substance per dose will be used.
II.
("Animal Pain: Perception and Alleviation." Kitchell, R.L., Erickson, H.H., Carstens, E. and
Davis, L.E., editors. Am. Physiol. Soc. 1983, Williams and Wilkins, Baltimore).
The following is a partial list of procedures known to involve significant pain and/or distress:
1.
2.
3.
4.
Version: 4-2008
b. There are three categories to choose from. The following describe each category.
A. NONE OR MINOR
Procedures which are considered to produce minimal, transient, or no pain or distress
when performed by competent individuals. These include chronic studies that DO
NOT involve survival surgery, induction of painful or stressful disease conditions, or
pain or distress in excess of that associated with routine injections or blood collection.
Included are induction or transplantation of tumors in animals (so long as the tumors
do not cause pain and the animals are terminated prior to becoming serious ill),
administration of mildly toxic substances or drugs that cause no significant disease or
distress, and antibody production (antigen inoculations and blood collection) as long
as significant disease does not result.
B. EXPERIMENTS INVOLVING PAIN AND/OR DISTRESS WITH
ANESTHESIA/ANALGESIA
If you plan to conduct studies which involves any of the procedures defined in (a)
above or any other procedure which in your estimation involves significant pain
and/or distress, the animal must be given appropriate anesthetics or analgesics to
prevent or alleviate pain (tranquilizers for distress).
C. PAIN WITHOUT ANESTHESIA/ANALGESIA
If the nature of the study prohibits the use of pain and/or stress relieving drugs, or if unavoidable
and unalleviable pain or distress will be produced, you must provide a written justification.
These include: direct stimulation of CS pain tracts, nociceptor stimulation by physical or
chemical means that cause severe pain (e.g., corneal abrasions), or any category (see above)
procedure if performed without chemical relief of pain.
III.
IV.
General Purpose of Project (check all that apply) Basic Procedure (check all that apply)
X
___
___
___
___
Research Project
Pilot Project
Teaching Project
Student Special Project
___
___
___
___
Blood/Tissue Collection
Surgical Lesion
Pharmacological
Behavioral
___
___
Anesthetics
___
Restraint Devices
___
___
Breeding Colony (If yes, include Breeding Colony Application [see Research Office])
Version: 4-2008
PI:
2. FUNDING (Current and Pending)
A. Extramural Funding
When more than one funding source is solicited, a single application may be submitted
for approval provided species, number, and procedures are compatible.
N/A
Agency: ______________________________________________________________
B. Intramural Funding
N/A
N/A
Funding Source: ________________________Begin/End
dates:___________________
3. SCIENTIFIC MERIT (Briefly explain the scientific merit of your proposal to justify the use
of animals to any reasonable and well-informed lay person. This should include your project's
relevance to human or animal health and/or the advancement of knowledge. Include the rationale
for the choice of species and number of animals used. Limit your response to the space below)
THIS PROJECT WILL BE DONE IN CONJUNCTION WITH THE SUSTAINABLE ENERGY FOR NEEDY
AND EMERGING AREAS (SENEA) GROUP IN THE UNIVERSITY. THIS AQUAPONICS PROJECT IS
AIMED TOWARDS CREATING A SYSTEM THAT CAN EASILY BE DELIVERED TO DEVELOPING AREAS
AND ALSO ONE THAT IS LOW COST TO BUILD AND TO MAINTAIN. WHILE THERE HAS BEEN
RESEARCH DONE ANALYZING THE TILAPIA'S USE IN AN AQUAPONICS SYSTEM, THERE HASN'T
BEEN ONE DEVELOPED FOR EMERGING AREAS YET AND WE PLAN ON DOING THAT. SUCCESSFULLY
CREATING THIS SYSTEM WILL ALLOW FOR AREAS TO HAVE A SUSTAINABLE SYSTEM THAT WOULD
PRODUCE BOTH FISH AND VEGETABLES IN PLACES WHERE THERE MIGHT NOT BE A LOT OF LAND
OR UNFAVORABLE WEATHER AND CLIMATE TO GROW FOOD. IN ORDER TO PACKAGE THE SYSTEM
EASILY FOR DELIVERY, WE DECIDED TO USE 3 55-GALLON DRUM TANKS AND IN ORDER TO
MAXIMIZE THEIR POTENTIAL, WE FOLLOWED THE RULE OF 40 FISH PER 140 GALLONS TO
JUSTIFY THE USE OF 50 TILAPIA. NILE TILAPIA SPECIFICALLY IS THE SPECIES THAT WE
PLAN ON USING AND IS GOOD FOR EMERGING AREAS FOR ITS QUICK MATURITY TO BE USED
AS FOOD AND ALSO ITS HARDINESS IN ALL ENVIRONMENTS AND ITS DIET OF PLANT MATTER
THAT COULD BE PROVIDED BY ANYONE NO MATTER WHERE THE SYSTEM IS IN THE WORLD.
ATTACHED TO THIS IS ALSO OUR RESEARCH PROPOSAL WHICH OUTLINES OUR OBJECTIVES,
PROCEDURES AND
Version: 4-2008
PI:
4.
ANIMALS TO BE USED
WHITE BROOK WHITE NILE TILAPIA
Species O. NILOTICUS
Strain______________
Vendor WHITE BROOK TILAPIA FARM
~11.5g
# per year 50
Weight_________
Age ~30 days
Species
Vendor
# per year
Strain______________
Weight_________
Age
Species______________
Strain______________
Vendor__________________________________
# per year______
Weight_________
Age________
Species______________
Strain______________
Vendor__________________________________
# per year______
Weight_________
Age________
Species______________
Strain______________
Vendor__________________________________
# per year______
Weight_________
Age________
Species______________
Strain______________
Vendor__________________________________
# per year______
Weight_________
Age________
Describe any special housing needs: (light cycles, temperature, isolation, cage & bedding, etc)
WE PLAN ON USING PLASTIC DRUMS TO HOUSE THE FISH. NECESSARY ITEMS SUCH
AS AIR STONES AND AIR PUMPS TO KEEP THE WATER AERATED, FILTERS INITIALLY
FOR RAISING THE TILAPIA FINGERLINGS TO PUMPS TO PUMP THE WASTE INTO
THE AQUAPONICS SYSTEM LATER, AND TEMPERATURE TUBES TO KEEP THE SYSTEM CONSTANT.
Version: 4-2008
5.
PAIN/DISTRESS CATEGORY
(Give number of animals in each category - A, B, or C. See cover page. Please make sure it matches
the number of animals stated in #4 above.) If any animals are placed under category C, attach a
written justification to the protocol.
50 WHITE NILE TILAPIA WILL BE USED AND THEY WILL ALL BE CATEGORY A. NO
HARM WILL COME TO THEM AND THEY WOULD ONLY BE USED TO COLLECT THEIR
WASTE TO BE REINTRODUCED INTO THE AQUAPONICS CYCLE.
6.
Version: 4-2008
PI:
7.
QUALIFICATIONS (The Animal Welfare Act requires that all personnel involved in the care,
treatment and use of animals be quailified to perform their duties. Please provide information
which indicates that you and others involved on this project are qualified to perform the
procedures described in #6 above.)
I HAVE PERSONALLY RAISED FISH AND OTHER ANIMALS SINCE I WAS A KID
INCLUDING HOLLAND LOPS, STICK INSECTS AND KOI. I ASSISTED MY DAD WHEN
BUILDING OUR KOI POND AND FILTER SYSTEM AND AM IN CHARGE OF REGULARLY
MAINTAING THE POND'S CLEANLINESS AND ROUTINE MAINTENANCE ON THE FILTERS.
8.
9.
COMMON FISH INFECTIONS SUCH AS DROPSY, ICK AND FIN ROT CAN BE TREATED
WITH PET-STORE-BOUGHT MEDICINES, BUT I AM CONFIDENT THAT PROPER PH,
AMMONIA LEVELS, TEMPERATURE AND MAINTENANCE WILL PREVENT ANYTHING FROM
HAPPENING TO THE FISH.
REMOVAL FROM THE TANK DURING WATER CHANGES WILL CAUSE STRESS TO THE FISH.
Version: 4-2008
PI:
10 EUTHANASIA (Check that which applies.)
____
A.
____
B.
Injectable Agents (Please provide specific drug, dosage, and route of administration.)
X
____
C.
Physical Methods
____ Cervical dislocation (animals <200 grams)
____
X Decapitation with guillotine
Yes____ No____
X
If no, provide scientific justification for performing this procedure without sedation/anesthesia (e.g.
interference with specific experimental parameters).
____
D.
____
E.
Version: 4-2008
PI:
11.
ASSURANCES
a. Alternatives: The Animal Welfare Act requires that the principal investigator has
considered alternatives to the use of animals. Provide a description of the methods
and sources (e.g. Biological Abstracts, Index Medicus, Current Research Information
Service, or the National Agricultural Library) used to determine that alternatives
were not available. Please provide two sources if possible.
WE RESEARCHED THE FISH THAT COULD BE USED TO STUDY AQUAPONICS
AND WE DECIDED TO USE SPECIFICALLY TILAPIA COMPARED TO OTHERS
INCLUDING KOI AND GOLDFISH BECAUSE TILAPIA IS EASILY ACCESSIBLE
IN MANY PARTS OF THE WORLD AND EVEN INVASIVE IN AUSTRALIA. ALSO,
THE DIET OF THE TILAPIA DOES NOT REQUIRE SPECIFIC FEED AND CAN
BE FED ALMOST ANY PLANT MATTER. (Barlow, G. W. (2000). The Cichlid
Fishes. Cambridge, MA: Perseus Publishing. ISBN 0-7382-0376-9.)
ITS QUICK MATURITY RATE ALSO ALLOWS FOR IT TO BE USED AS A FOOD
SOURCE IF THIS SYSTEM IS IMPLEMENTED IN A DEVELOPING COUNTRY OR
COMMUNITY GARDEN. (http://sta.uwi.edu/fst/lifesciences/documents/
Oreochromis_niloticus.pdf)
b. Duplication: The Animal Welfare Act requires that the principal investigator has
provided assurance that the research activities do not unnecessarily duplicate
previous experiments. Provide a description of the methods and sources used to
determine the proposed research does not unnecessarily duplicate previous
experiments.
c. Number of animals: All appropriate regulations stipulate that the number of animals
to be used in a procedure should be the minimum number required to obtain valid
results. Please justify the number of animals you listed for this study. If possible,
justify statistically.
Version: 4-2008
PI:
12.
COMPLIANCE STATEMENTS
I agree to abide by the TU policies for the care and use of animals as outlined in the provisions of the NIH
Guide to the Care and Use of Laboratory Animals, and all federal, state, and local laws and regulations
governing the use of animals in research, teaching, and testing.
I understand that emergency care and treatment will be administered to animals if needed, in addition to
routine veterinary care.
I declare that all experiments performed on live animals will be performed under my supervision or that
of another qualified biomedical scientist listed in this proposal.
I assure that personnel with animal or animal tissue contact have been informed of safety and risk
hazards.
I further declare that the information given in this protocol is accurate to the best of my knowledge. Any
proposed revisions to this protocol should be forwarded to the IACUC for approval including changes in
personnel and location.
P.I. Signature:___________________________
Date:______________
9-12-2014
Typed Name:
APPROVAL:
______________________________________
____________________
9-12-2014
IACUC Chair
Date:
Version: 4-2008
P.I. Name:
FORM A
SUPPLEMENTAL SHEET FOR ALL ANIMAL USE APPLICATIONS
INVOLVING SURVIAL SURGICAL PROCEDURES
PROTOCOL #:
SPECIES:
Anesthesiologists:
Assisting Surgeons:
Technicians:
At this point, be sure that all items (#6, 7, 8, &9) relating to pre- and post-operative care
under Surgical Procedures have been addressed.
Any procedural changes must be submitted as an amendment to the protocol for review
and approval prior to initiating these changes. All personnel working in direct contact
with animals on this project must be listed on the protocol and must complete a personal
statement.
________________________________
Principle Investigator Signature
Version: 4-2008
__________________________________
Typewritten Name
P.I. Name:
FORM B
ANIMAL EXPERIMENTATION INVOLVING HAZARDOUS AGENTS
Complete only if applicable to your project. If not, please remove from packet.
For applications using hazardous agents or radioisotopes, the research project must be registered
with The University of Tulsa HAAZCOM Office prior to submission of this application.
Approved Authorization Number:
1.
Study involves:
__Radioactive Materials
__Chemical Carcinogens
__Acute Toxins
2.
Identify Hazardous Agent(s) and animals or tissues used:
Animal/Tissue
Agent
Dosage or Amount Used
Route
Frequency
__________________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________
3.
Risks to:
___Animals ___Humans
If yes, describe the potential health risks to humans or animals:
6. Describe special animal care required relating to the use of Harrods materials:
______________________________
Version: 4-2008
_______________________________
Version: 4-2008
Typewritten Name